{"result": "```json\n{\n    \"title\": \"Prostate Cancer Treatment Community\",\n    \"summary\": \"The community focuses on various compounds used in the treatment of prostate cancer, including Etoposide, Nilutamide, and Mitoxantrone. These entities are interconnected through their therapeutic applications and shared side effects, highlighting their significance in oncology.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical role these compounds play in treating prostate cancer and their associated side effects.\",\n    \"findings\": [\n        {\n            \"summary\": \"Etoposide's multifaceted role in cancer treatment\",\n            \"explanation\": \"Etoposide is a topoisomerase inhibitor that is utilized in treating various cancers, including prostate cancer, vaginal cancer, and urinary bladder cancer. Its mechanism of action involves interfering with DNA replication, making it effective against malignancies. However, it is also associated with side effects such as abdominal pain and agranulocytosis, which necessitate careful monitoring during treatment. Etoposide's connections to multiple cancer types underscore its importance in oncology [Data: Entities (154); Relationships (427, 429, 428)]\"\n        },\n        {\n            \"summary\": \"Nilutamide's specific application in prostate cancer\",\n            \"explanation\": \"Nilutamide is an androgen receptor antagonist primarily used for prostate cancer treatment. While effective, it is associated with side effects like abdominal pain and alopecia. Its therapeutic relationship with other compounds, such as Etoposide and Epirubicin, indicates its significance in combination therapies for prostate cancer, enhancing treatment efficacy while managing potential adverse effects [Data: Entities (129); Relationships (280, 343)]\"\n        },\n        {\n            \"summary\": \"Mitoxantrone's role in treating multiple cancers\",\n            \"explanation\": \"Mitoxantrone is another topoisomerase inhibitor used in treating prostate cancer, lymphatic system cancer, and sarcoma. Its effectiveness in disrupting DNA replication in cancer cells is crucial for managing these malignancies. However, it also presents side effects, including anxiety and arrhythmia, which require careful patient management. The relationships Mitoxantrone shares with other compounds highlight its importance in comprehensive cancer treatment strategies [Data: Entities (158); Relationships (440, 439)]\"\n        },\n        {\n            \"summary\": \"The significance of estrogen receptor agonists\",\n            \"explanation\": \"Compounds like Ethinyl Estradiol and Conjugated Estrogens, classified as estrogen receptor agonists, are utilized in treating prostate cancer and osteoporosis. Their therapeutic applications are critical, especially in managing symptoms associated with hormone-sensitive cancers. However, they also come with side effects, including anxiety and abdominal pain, which must be considered in treatment plans. The interconnectedness of these compounds with other cancer treatments emphasizes their role in holistic cancer care [Data: Entities (155, 156); Relationships (434, 437)]\"\n        },\n        {\n            \"summary\": \"The interconnectedness of cancer treatment compounds\",\n            \"explanation\": \"The compounds within this community are highly interconnected through their therapeutic applications for prostate cancer. For instance, Etoposide, Nilutamide, and Epirubicin are all used to treat prostate cancer, indicating a collaborative approach in oncology. This interconnectedness suggests that treatment regimens may often involve combinations of these compounds to enhance efficacy while managing side effects. Understanding these relationships is vital for developing effective treatment protocols [Data: Relationships (416, 423, 425)]\"\n        }\n    ]\n}\n```", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n154,ETOPOSIDE,\"Etoposide is a compound classified as a topoisomerase inhibitor, utilized in the treatment of various types of cancer, including prostate cancer, vaginal cancer, sarcoma, and urinary bladder cancer. This medication is known to have side effects, which may include abdominal pain and agranulocytosis. Etoposide's mechanism of action involves interfering with the DNA replication process, making it effective against these malignancies.\",11\n155,ETHINYL ESTRADIOL,\"Ethinyl Estradiol is a compound classified as an Estrogen Receptor Agonist. It is utilized in various medical contexts, including the treatment of prostate cancer and the palliation of symptoms associated with Polycystic Ovary Syndrome. Additionally, Ethinyl Estradiol is employed in the management of osteoporosis. The compound is known to have several side effects, which may include anxiety, abdominal pain, and breast disorders.\",10\n156,CONJUGATED ESTROGENS,\"Conjugated Estrogens is a compound classified as an Estrogen Receptor Agonist. It is utilized in the treatment of both prostate cancer and osteoporosis. The compound is associated with several side effects, which include acidosis, abdominal cramps, and anaphylactic shock.\",9\n152,EPIRUBICIN,\"Epirubicin is a compound classified as a Topoisomerase Inhibitor, primarily used in the treatment of various types of cancer, including stomach cancer, prostate cancer, and sarcoma. This medication is associated with several side effects, which may include lactic acidosis, agranulocytosis, and abdominal distension. As a versatile treatment option, Epirubicin plays a significant role in oncology, targeting different cancer types while presenting a range of potential adverse effects that require monitoring.\",10\n129,NILUTAMIDE,\"Nilutamide is a compound classified as an androgen receptor antagonist, primarily used in the treatment of prostate cancer. This medication is known to be effective in managing the disease, but it is also associated with several side effects, including abdominal pain and alopecia.\",10\n158,MITOXANTRONE,\"Mitoxantrone is a compound classified as a topoisomerase inhibitor, utilized in the treatment of various types of cancer, including prostate cancer, lymphatic system cancer, and sarcoma. This medication is associated with a range of side effects, which may include anxiety, arrhythmia, abdominal pain, and agranulocytosis. Its role as a topoisomerase inhibitor makes it effective in disrupting the DNA replication process in cancer cells, thereby aiding in the management of these malignancies.\",10\n157,ABIRATERONE,\"Abiraterone is a compound with no specific pharmacologic class mentioned, used to treat prostate cancer, with side effects including arrhythmia and chest pain.\",8\n150,ESTRADIOL,\"Estradiol is a compound classified as an Estrogen Receptor Agonist used to treat prostate cancer, with side effects including abdominal cramps and anaphylactic shock.\",8\n151,PREDNISONE,\"Prednisone is a compound classified as a Corticosteroid Hormone Receptor Agonist used to treat prostate cancer, with side effects including abdominal distension and adrenal insufficiency.\",8\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n427,ETOPOSIDE,VAGINAL CANCER,Etoposide can treat Vaginal Cancer,42\n434,ETHINYL ESTRADIOL,OSTEOPOROSIS,\"Ethinyl estradiol is used to treat osteoporosis, with several side effects\",41\n437,CONJUGATED ESTROGENS,OSTEOPOROSIS,\"Conjugated estrogens are used to treat osteoporosis, with several side effects\",40\n421,EPIRUBICIN,STOMACH CANCER,Epirubicin is a compound that treats Stomach Cancer,40\n429,ETOPOSIDE,URINARY BLADDER CANCER,Etoposide is a compound used to treat Urinary Bladder Cancer,40\n280,PROSTATE CANCER,NILUTAMIDE,Nilutamide is used to treat Prostate Cancer,40\n428,ETOPOSIDE,SARCOMA,\"Etoposide is used to treat Sarcoma, indicating a direct therapeutic relationship\",39\n422,EPIRUBICIN,SARCOMA,\"Epirubicin is used to treat Sarcoma, indicating a direct therapeutic relationship\",38\n440,MITOXANTRONE,SARCOMA,\"Mitoxantrone is used to treat Sarcoma, indicating a direct therapeutic relationship\",38\n143,ABDOMINAL PAIN,NILUTAMIDE,Nilutamide can cause abdominal pain as a side effect,29\n439,MITOXANTRONE,LYMPHATIC SYSTEM CANCER,Mitoxantrone is used to treat Lymphatic System Cancer,24\n416,EPIRUBICIN,ETOPOSIDE,\"Both Epirubicin and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n423,ETOPOSIDE,ETHINYL ESTRADIOL,\"Both Etoposide and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n426,ETOPOSIDE,MITOXANTRONE,\"Both Etoposide and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n343,NILUTAMIDE,ETOPOSIDE,\"Both Nilutamide and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",21\n424,ETOPOSIDE,CONJUGATED ESTROGENS,\"Both Etoposide and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n417,EPIRUBICIN,ETHINYL ESTRADIOL,\"Both Epirubicin and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n420,EPIRUBICIN,MITOXANTRONE,\"Both Epirubicin and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n342,NILUTAMIDE,EPIRUBICIN,\"Both Nilutamide and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n432,ETHINYL ESTRADIOL,MITOXANTRONE,\"Both Ethinyl Estradiol and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n344,NILUTAMIDE,ETHINYL ESTRADIOL,\"Both Nilutamide and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n347,NILUTAMIDE,MITOXANTRONE,\"Both Nilutamide and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",20\n425,ETOPOSIDE,ABIRATERONE,\"Both Etoposide and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n436,CONJUGATED ESTROGENS,MITOXANTRONE,\"Both Conjugated Estrogens and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n345,NILUTAMIDE,CONJUGATED ESTROGENS,\"Both Nilutamide and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n418,EPIRUBICIN,CONJUGATED ESTROGENS,\"Both Epirubicin and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n430,ETHINYL ESTRADIOL,CONJUGATED ESTROGENS,\"Both Ethinyl Estradiol and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n405,ESTRADIOL,ETOPOSIDE,\"Both Estradiol and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n411,PREDNISONE,ETOPOSIDE,\"Both Prednisone and Etoposide are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",19\n438,ABIRATERONE,MITOXANTRONE,\"Both Abiraterone and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n346,NILUTAMIDE,ABIRATERONE,\"Both Nilutamide and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n419,EPIRUBICIN,ABIRATERONE,\"Both Epirubicin and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n431,ETHINYL ESTRADIOL,ABIRATERONE,\"Both Ethinyl Estradiol and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n404,ESTRADIOL,EPIRUBICIN,\"Both Estradiol and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n410,PREDNISONE,EPIRUBICIN,\"Both Prednisone and Epirubicin are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n406,ESTRADIOL,ETHINYL ESTRADIOL,\"Both Estradiol and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n409,ESTRADIOL,MITOXANTRONE,\"Both Estradiol and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n340,NILUTAMIDE,ESTRADIOL,\"Both Nilutamide and Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n412,PREDNISONE,ETHINYL ESTRADIOL,\"Both Prednisone and Ethinyl Estradiol are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n415,PREDNISONE,MITOXANTRONE,\"Both Prednisone and Mitoxantrone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n341,NILUTAMIDE,PREDNISONE,\"Both Nilutamide and Prednisone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",18\n435,CONJUGATED ESTROGENS,ABIRATERONE,\"Both Conjugated Estrogens and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",17\n407,ESTRADIOL,CONJUGATED ESTROGENS,\"Both Estradiol and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",17\n413,PREDNISONE,CONJUGATED ESTROGENS,\"Both Prednisone and Conjugated Estrogens are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",17\n408,ESTRADIOL,ABIRATERONE,\"Both Estradiol and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",16\n414,PREDNISONE,ABIRATERONE,\"Both Prednisone and Abiraterone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",16\n403,ESTRADIOL,PREDNISONE,\"Both Estradiol and Prednisone are compounds used to treat prostate cancer, indicating a relationship in their therapeutic application.\",16\n433,ETHINYL ESTRADIOL,POLYCYSTIC OVARY SYNDROME,Ethinyl Estradiol is used to palliate symptoms of Polycystic Ovary Syndrome,16\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}